Ledger.Open graph →
SEC Form D · filed May 18, 2016

Ascendance Biotechnology, Inc

Offering
$300K
Sold
$230K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MEDFORD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

John K. Mcgeehan · Medford, MAExec · PromoterJeffrey D. Janus · Medford, MAExec · Director · PromoterVincent R. Zurawski · Medford, MAExec · Director · PromoterMartin J. Joyce · Medford, MAExecNeil Milne · Warsaw, R9Exec · PromoterGeorge Swirski · Warsaw, R9Exec · Director · PromoterStephen Richmond · Warsaw, R9Exec · Director · PromoterMichael D. West · Medford, MADirectorAlfred D. Kingsley · Medford, MADirectorRobert G. Wilkens · Medford, MADirectorMorton D. Collins · Medford, MADirectorJames L. Nederlander · New York, NYExec · Director · PromoterCharles V. Long · Oklahoma City, OKExec · Director · PromoterAndrew G. Dodson · SAN FRANCISCO, CAExec · PromoterMichael D. West · Medford, MADirectorAlfred D. Kingsley · Medford, MADirectorRobert G. Wilkens · Medford, MADirectorMorton D. Collins · Medford, MADirectorMartin J. Joyce · Medford, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗